Clinically significant cancer evolves from transient mutated and/or aneuploid neoplasia by cell fusion to form unstable syncytia that give rise to ecologically viable parasite species
- 1 January 2005
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 65 (5) , 846-850
- https://doi.org/10.1016/j.mehy.2005.05.036
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Information dynamics in carcinogenesis and tumor growthMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidyProceedings of the National Academy of Sciences, 2000
- Aneuploidy, the somatic mutation that makes cancer a species of its ownCell Motility, 2000
- Genetic toxicology data in the evaluation of potential human environmental carcinogensMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1999
- How aneuploidy affects metabolic control and causes cancerBiochemical Journal, 1999
- The cellular ecology of progressive neoplastic transformation: A clonal analysisProceedings of the National Academy of Sciences, 1999
- Aneuploidy correlated 100% with chemical transformation of Chinese hamster cellsProceedings of the National Academy of Sciences, 1997
- Models of Tumor-Host Interaction as Competing Populations: Implications for Tumor Biology and TreatmentJournal of Theoretical Biology, 1995
- Multistage Risk Models and the Age Pattern in Familial Polyposis coliCancer Investigation, 1984
- Artificial Transmutation of the GeneScience, 1927